SCHEMBL23911765

SCHEMBL23911765

CC1CC2CC(C2)CC(C)(C(C)N)C1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC22A2 O15244 2/20 0.48
SLC47A1 Q96FL8 2/20 0.48
MAPT P10636 1/20 0.47
SMN1; SMN2 Q16637 2/20 0.32
LMNA P02545 2/20 0.31
SLC22A1 O15245 1/20 0.31
GRIN2D O15399 1/20 0.31
GRIN3B O60391 1/20 0.31
TSHR P16473 1/20 0.31
NFKB1 P19838 1/20 0.31
STAT6 P42226 1/20 0.31
GRIN1 Q05586 1/20 0.31
GRIN2A Q12879 1/20 0.31
GRIN2B Q13224 1/20 0.31
GRIN2C Q14957 1/20 0.31
GRIN3A Q8TCU5 1/20 0.31
SIGMAR1 Q99720 1/20 0.31
EPHX1 P07099 1/20 0.31
NPC1 O15118 1/20 0.31
ALDH1A1 P00352 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21508113 0.92 SLC22A2 (0.52) SLC22A2SLC47A1MAPTSMN1; SMN2LMNA
SCHEMBL23948397 0.79 SLC22A2 (0.50) SLC22A2SLC47A1MAPTSMN1; SMN2LMNA
SCHEMBL19696242 0.75 SLC22A2 (0.46) SLC22A2SLC47A1MAPTSMN1; SMN2GRIN2D
SCHEMBL25965508 0.74 SLC22A2 (0.39) SLC22A2SLC47A1MAPTSMN1; SMN2LMNA
SCHEMBL18735261 0.72 SLC22A2 (0.74) SLC22A2SLC47A1MAPTSMN1; SMN2GRIN2D
SCHEMBL19484612 0.68 SLC22A2 (0.33) SLC22A2SLC47A1MAPTGRIN2DGRIN3B
SCHEMBL19484821 0.68 SLC22A2 (0.33) SLC22A2SLC47A1MAPTSMN1; SMN2GRIN2D
Rimantadine SCHEMBL2981 0.66 SLC22A2 (1.00) SLC22A2SLC47A1MAPTSMN1; SMN2LMNA
Rimantadine SCHEMBL20409367 0.66 SLC22A2 (1.00) SLC22A2SLC47A1MAPTSMN1; SMN2LMNA
Rimantadine SCHEMBL29908943 0.66 SLC22A2 (1.00) SLC22A2SLC47A1MAPTSMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11141385-B2 Sulfur (VI) fluoride compounds and methods for the preparation thereof THE SCRIPPS RESEARCH INSTITUTE (US) 2021-10-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11141385-B2 Sulfur (VI) fluoride compounds and methods for the preparation thereof CYP2F1, CYP2S1, NAF1 SLC22A2 2027/4885SLC47A1 3494/4885MAPT 4173/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.